Diplomat Pharmacy (DPLO) to Dispense DUPIXENT to Treat Atopic Dermatitis
Tweet Send to a Friend
Diplomat Pharmacy, Inc. (NYSE: DPLO) will have access to dispense DUPIXENT® (dupilumab), recently approved by the Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE